Pre-transplant gene profiling characterization by next-generation DNA sequencing might predict relapse occurrence after hematopoietic stem cell transplantation in patients affected by AML.

Front Oncol · 2022 · PMC9768016 · PMID 36568206

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

did not reach statistical significancep=0.07so close (0.05 < p ≤ 0.1)

Finally, patients triple mutated for NPM1, FLT3, and DNMT3A (n=10) had a 1-year cumulative incidence of relapse of 50% as compared to 25.9% in others, but the difference did not reach statistical significance (p=0.07).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.